Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 5/20 | 0.41 |
| ▸ | RAB9A | P51151 | 5/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2333379 | 1.00 | NPC1 (0.41) | NPC1RAB9ASMN1; SMN2MAPTCYP1A2 | |
| SCHEMBL2564341 | 0.98 | NPC1 (0.42) | NPC1RAB9ASMN1; SMN2MAPTCYP1A2 | |
| SCHEMBL2565267 | 0.80 | NPC1 (0.40) | NPC1RAB9ASMN1; SMN2MAPTCYP1A2 | |
| SCHEMBL2565047 | 0.79 | SMN1; SMN2 (0.39) | NPC1RAB9ASMN1; SMN2MAPTCYP1A2 | |
| SCHEMBL2565240 | 0.79 | NPC1 (0.42) | NPC1RAB9ASMN1; SMN2MAPTCYP1A2 | |
| SCHEMBL2564868 | 0.75 | NPC1 (0.41) | NPC1RAB9ASMN1; SMN2MAPTALDH1A1 | |
| SCHEMBL2568762 | 0.75 | NPC1 (0.41) | NPC1RAB9ASMN1; SMN2MAPTALDH1A1 | |
| SCHEMBL4639985 | 0.75 | NPC1 (0.40) | NPC1RAB9ASMN1; SMN2MAPTCYP1A2 | |
| SCHEMBL2564865 | 0.75 | NPC1 (0.41) | NPC1RAB9ASMN1; SMN2MAPTALDH1A1 | |
| Benzene SCHEMBL28160719 | 0.74 | NPC1 (0.49) | NPC1RAB9ASMN1; SMN2MAPTCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4214303-B1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2026-05-06 | — | — | EP | claimed |
| WO-2025202258-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2025-10-02 | — | — | WO | claimed |
| EP-3325588-B1 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2025-04-16 | — | — | EP | claimed |
| CN-119698458-A | Improvements in or relating to organic compounds improvements relating to organic compounds | 诺维信公司 | 2025-03-25 | — | — | CN | claimed |
| EP-4214303-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2023-07-26 | — | — | EP | claimed |
| CN-116323891-A | Improvements in or relating to organic compounds | 奇华顿股份有限公司 | 2023-06-23 | — | — | CN | claimed |
| EP-4139041-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2023-03-01 | — | — | EP | claimed |
| CN-115666494-A | Encapsulated compositions comprising core-shell microcapsules and methods of making the same | 奇华顿股份有限公司 | 2023-01-31 | — | — | CN | claimed |
| EP-4120991-A1 | CONSUMER PRODUCT COMPRISING A PLURALITY OF MICROCAPSULES DEFINED BY THE MEAN TOTAL SURFACE AREA | Givaudan SA (CH) | 2023-01-25 | — | — | EP | claimed |
| CN-115297822-A | Consumer product comprising a plurality of microcapsules defined by an average total surface area | 奇华顿股份有限公司 | 2022-11-04 | — | — | CN | claimed |
| WO-2022058048-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2022-03-24 | — | — | WO | claimed |
| WO-2025202258-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2025-10-02 | — | — | WO | disclosed |
| EP-4557951-A1 | COMPOSITION COMPRISING BIODEGRADABLE MICROCAPSULES | Givaudan SA (CH) | 2025-05-28 | — | — | EP | disclosed |
| EP-4554405-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2025-05-21 | — | — | EP | disclosed |
| CN-119698458-A | Improvements in or relating to organic compounds improvements relating to organic compounds | 诺维信公司 | 2025-03-25 | — | — | CN | disclosed |
| EP-4021629-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2022-07-06 | — | — | EP | disclosed |
| CN-114340775-A | Improvements in or relating to organic compounds | 奇华顿股份有限公司 | 2022-04-12 | — | — | CN | disclosed |
| CN-110573244-B | Improvements in or relating to organic compounds | 奇华顿股份有限公司 | 2022-04-01 | — | — | CN | disclosed |
| EP-3972554-A1 | CORE-SHELL ENCAPSULATED COMPOSITION COMPRISING A BENEFIT AGENT | Givaudan SA (CH) | 2022-03-30 | — | — | EP | disclosed |
| WO-2022058048-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2022-03-24 | — | — | WO | disclosed |